Jianping Huang

1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.

S. A. Watkins, C. D. Spencer, N. Stamm, 2004, Bioorganic & medicinal chemistry letters.

1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.

S. A. Watkins, C. D. Spencer, N. Stamm, 2004, Bioorganic & medicinal chemistry letters.

Identification of 2(1H)-pyrimidinones as potential EGFR T790M inhibitors for the treatment of gefitinib-resistant non-small cell lung cancer.

Xiaodong Ma, Changyuan Wang, Guoping Huang, 2019, Bioorganic chemistry.

Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.

S. A. Watkins, R. Schultz, Faming Zhang, 2004, Bioorganic & medicinal chemistry letters.

A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours.

A. Tolcher, K. Papadopoulos, A. Patnaik, 2014, European journal of cancer.

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases.

G. Wang, Guan Wang, Wei Liu, 2022, Drug discovery today.

Abstract 4973: Discovery of LY3214996, a selective and novel ERK1/2 inhibitor with potent antitumor activities in cancer models with MAPK pathway alterations

J. Manro, Sheng-Bin Peng, W. Mcmillen, 2017 .